Table 1.
Clinical characteristics of type 1 diabetes patients.
| Clinical features | T1D | Severe T1D onset | Mild T1D onset |
|---|---|---|---|
| n = 28 (%) | n = 12 (%) | n = 16 (%) | |
| Gender, F/M | 4/24 | ||
| Age† (y) | 11.21 ± 3.33 | 11.33 ± 3.63 | 11.63 ± 3.18 |
| BMI† (kg/m2) | 17.33 ± 3.05 | 17.31 ± 3.18 | 17.62 ± 3.09 |
| HbA1c† (%) | 10.66 ± 1.67 | 10.59 ± 1.15 | 11.16 ± 1.86 |
| C peptide† (nmol/l) | 0.30 ± 0.08 | 0.27 ± 0.9 | 0.32 ± 0.08 |
| 25-OH-D† (ng/ml) | 18.19 ± 7.68 | 13.98 ± 3.27∗∗ | 21.73 ± 8.76 |
| DKA‡ | 12 (43) | 12 (100) | 16 (0) |
| IAA‡ | 7 (25) | 3 (25) | 4 (25) |
| GADA‡ | 21 (75) | 9 (75) | 12 (75) |
| IA2A‡ | 23 (82) | 11 (92) | 12 (75) |
BMI: body mass index; HbA1c: glycated haemoglobin A1c; 25-OH-D: 25-hydroxyvitamin D; DKA: diabetic ketoacidosis; IAA: antibodies to insulin; GADA: antibodies to glutamic acid decarboxylase; IA2A: antibodies to islet antigen-2; clinical features presented as †mean ± standard deviation; ‡number of subjects (%); ∗∗P < 0.01, P values estimated by unpaired t-test, severe T1D onset vs. mild T1D onset subgroup.